Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene

Toxicology Letters

Volumn 213, Issue 2, 2012, Pages 299-304

  Verner, Marc Andre ^a   McDougall, Robin ^b   Johanson, Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

Author keywords

Biological limit value; Biomonitoring; Physiologically based pharmacokinetic (PBPK) modeling; Sampling; Styrene

Indexed keywords

STYRENE;

AIR CONDITIONING; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; EXPIRED AIR; MONTE CARLO METHOD; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; WORKING TIME; WORKLOAD;

AIR POLLUTANTS, OCCUPATIONAL; BREATH TESTS; COMPUTER SIMULATION; FEMALE; HUMANS; LIVER; MALE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; OCCUPATIONAL EXPOSURE; STYRENE;

EID: 84865167442     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.05.024     Document Type: Article

References (22)

1. Benignus V.A., Geller A.M., Boyes W.K., Bushnell P.J. Human neurobehavioral effects of long-term exposure to styrene: a meta-analysis. Environmental Health Perspectives 2005, 113:532-538.
2. Brodkin C.A., Moon J.D., Camp J., Echeverria D., Redlich C.A., Willson R.A., Checkoway H. Serum hepatic biochemical activity in two populations of workers exposed to styrene. Occupational and Environmental Medicine 2001, 58:95-102.
3. Carlsson A. Exposure to toluene: uptake, distribution and elimination in man. Scandinavian Journal of Work, Environment and Health 1982, 8:43-55.
4. Csanady G.A., Mendrala A.L., Nolan R.J., Filser J.G. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Archives of Toxicology 1994, 68:143-157.
5. Droz P.O., Guillemin M.P. Human styrene exposure: V. Development of a model for biological monitoring. International Archives of Occupational and Environmental Health 1983, 53:19-36.
6. Engstrom K., Riihimaki V., Laine A. Urinary disposition of ethylbenzene and m-xylene in man following separate and combined exposure. International Archives of Occupational and Environmental Health 1984, 54:355-363.
7. Hays S.M., Aylward L.L., LaKind J.S., Bartels M.J., Barton H.A., Boogaard P.J., Brunk C., DiZio S., Dourson M., Goldstein D.A., Lipscomb J., Kilpatrick M.E., Krewski D., Krishnan K., Nordberg M., Okino M., Tan Y.M., Viau C., Yager J.W. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regulatory Toxicology and Pharmacology 2008, 51:S4-S15.
8. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regulatory Toxicology and Pharmacology 2007, 47:96-109.
9. IARC Agents Reviewed by the IARC Monographs 2006, vols. 1-96. International Agency for Research on Cancer, Lyon, France.
10. Johanson G., Naslund P.H. Spreadsheet programming - a new approach in physiologically based modeling of solvent toxicokinetics. Toxicology Letters 1988, 41:115-127.
11. Jonsson F., Johanson G. Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. Toxicology 2001, 157:177-193.
12. Jonsson F., Johanson G. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach. Toxicology and Applied Pharmacology 2002, 179:35-49.
13. Kishi R., Tozaki S., Gong Y.Y. Impairment of neurobehavioral function and color vision loss among workers exposed to low concentration of styrene - a review of literatures. Industrial Health 2000, 38:120-126.
14. Kumagai S., Matsunaga I., Kusaka Y. Autocorrelation of short-term and daily average exposure levels in workplaces. American Industrial Hygiene Association Journal 1993, 54:341-350.
15. Lof A., Johanson G. Dose-dependent Kinetics of Inhaled Styrene in Man 1993, IARC Sci Publ, pp. 89-99.
16. McDowell M.A., Fryar C.D., Ogden C.L., Flegal K.M. Anthropometric Reference Data for Children and Adults: United States, 2003-2006. National Health Statistics Reports; No. 10 2008, National Center for Health Statistics, Hyattsville, USA.
17. Mork A.K., Johanson G. Chemical-specific adjustment factors for intraspecies variability of acetone toxicokinetics using a probabilistic approach. Toxicological Sciences 2010, 116:336-348.
18. Poli D., Carbognani P., Corradi M., Goldoni M., Acampa O., Balbi B., Bianchi L., Rusca M., Mutti A. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respiratory Research 2005, 6:71.
19. Ramsey J.C., Andersen M.E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 1984, 73:159-175.
20. Sato T., Kishi R., Gong Y., Katakura Y., Kawai T. Effects of styrene exposure on vibration perception threshold. Neurotoxicology 2009, 30:97-102.
21. SWEA, 2011. Occupational Exposure Limit Values, vol. AFS 2011:18. Swedish Work Environment Authority, Solna.
22. Truchon G., Brochu M., Tardif R. Effect of physical exertion on the biological monitoring of exposure to various solvents following exposure by inhalation in human volunteers: III. Styrene. Journal of Occupational and Environmental Hygiene 2009, 6:460-467.